OUR PARTNERS
Major Partner
Founded in 1977, Balt is a pioneering family company, always leading in Interventional Neuroradiology. Balt completely controls its R&D policy with the constant underlying objective of innovating, making it one of the world Id leaders in its field. Constantly growing, Balt remains the one and only European company facing multinationals.
SUPPORTER Partners
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care.
Acandis specialises in the development, manufacturing and marketing of innovative products for the treatment of neurovascular diseases.
Our products are used by interventional neuroradiologists for prevention and treatment of stroke – for the benefit of patients!
CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.
MicroVention provides a complete 360-degree approach to developing neuroendovascular technologies and currently consists of four main product groups: Aneurysm Therapy Solutions, Ischemic Stroke and Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products. Additionally, our extensive product lines in each category allow our customers to uniquely address and customize the needs of their patients for many types of situations. Looking toward the future, we are committed to excellence in everything we do, and we strive to continually improve and innovate. We are dedicated to achieving results that exceed expectations -our own and our customers’.
Rapid Medical develops the premier responsive interventional devices for neurovascular diseases such as ischemic and hemorrhagic stroke. Utilizing novel manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible.
TIGERTRIEVER™ represents a new class of stent retrievers with remote intelligent control, allowing you to more effectively capture and retrieve blood clots.
COMANECI™ device enables wide-neck aneurysm embolization without blood supply interruptions nor permanent stent placement.
Wallaby Medical was founded with a focus on developing innovative, breakthrough, and clinically validated technologies and solutions for the treatment of neurovascular diseases. Wallaby Medical successfully acquired phenox GmbH, a leading global neurointerventional company based in Germany. As a result, we now offers a comprehensive and globally competitive portfolio of neurointerventional products, supported by multiple R&D centers and production bases, with a global team. the company’s vision is to "save more lives impacted by stroke."
For any information regarding sponsorship please contact:
Project Manager: Michel Wahba
E-mail: NICO@overcome.eu
Phone: +33 (0)1 40 88 97 97